Cargando…
GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia
Cortical gamma oscillations are believed to be involved in mental processes which are disturbed in schizophrenia. For example, the magnitudes of sensory-evoked oscillations, as measured by auditory steady-state responses (ASSRs) at 40 Hz, are robustly diminished, whereas the baseline gamma power is...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784891/ https://www.ncbi.nlm.nih.gov/pubmed/32859995 http://dx.doi.org/10.1038/s41386-020-00819-0 |
_version_ | 1783632366017708032 |
---|---|
author | Nakao, Kazuhito Singh, Mahendra Sapkota, Kiran Hagler, Bailey C. Hunter, Robert N. Raman, Chander Hablitz, John J. Nakazawa, Kazu |
author_facet | Nakao, Kazuhito Singh, Mahendra Sapkota, Kiran Hagler, Bailey C. Hunter, Robert N. Raman, Chander Hablitz, John J. Nakazawa, Kazu |
author_sort | Nakao, Kazuhito |
collection | PubMed |
description | Cortical gamma oscillations are believed to be involved in mental processes which are disturbed in schizophrenia. For example, the magnitudes of sensory-evoked oscillations, as measured by auditory steady-state responses (ASSRs) at 40 Hz, are robustly diminished, whereas the baseline gamma power is enhanced in schizophrenia. Such dual gamma oscillation abnormalities are also present in a mouse model of N-methyl-D-aspartate receptor hypofunction (Ppp1r2cre/Grin1 knockout mice). However, it is unclear whether the abnormal gamma oscillations are associated with dysfunction in schizophrenia. We found that glycogen synthase kinase-3 (GSK3) is overactivated in corticolimbic parvalbumin-positive GABAergic interneurons in Grin1 mutant mice. Here we addressed whether GSK3β inhibition reverses both abnormal gamma oscillations and behavioral deficits with high correlation by pharmacological and genetic approach. We demonstrated that the paralog selective-GSK3β inhibitor, but not GSK3α inhibitor, normalizes the diminished ASSRs, excessive baseline gamma power, and deficits in spatial working memory and prepulse inhibition (PPI) of acoustic startle in Grin1 mutant mice. Cell-type specific GSK3B knockdown, but not GSK3A knockdown, also reversed abnormal gamma oscillations and behavioral deficits. Moreover, GSK3B knockdown, but not GSK3A knockdown, reverses the mutants’ in vivo spike synchrony deficits. Finally, ex vivo patch-clamp recording from pairs of neighboring cortical pyramidal neurons showed a reduction of synchronous spontaneous inhibitory-postsynaptic-current events in mutants, which was reversed by GSK3β inhibition genetically and pharmacologically. Together, GSK3β inhibition in corticolimbic interneurons ameliorates the deficits in spatial working memory and PPI, presumably by restoration of synchronous GABA release, synchronous spike firing, and evoked-gamma power increase with lowered baseline power. |
format | Online Article Text |
id | pubmed-7784891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-77848912021-01-14 GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia Nakao, Kazuhito Singh, Mahendra Sapkota, Kiran Hagler, Bailey C. Hunter, Robert N. Raman, Chander Hablitz, John J. Nakazawa, Kazu Neuropsychopharmacology Article Cortical gamma oscillations are believed to be involved in mental processes which are disturbed in schizophrenia. For example, the magnitudes of sensory-evoked oscillations, as measured by auditory steady-state responses (ASSRs) at 40 Hz, are robustly diminished, whereas the baseline gamma power is enhanced in schizophrenia. Such dual gamma oscillation abnormalities are also present in a mouse model of N-methyl-D-aspartate receptor hypofunction (Ppp1r2cre/Grin1 knockout mice). However, it is unclear whether the abnormal gamma oscillations are associated with dysfunction in schizophrenia. We found that glycogen synthase kinase-3 (GSK3) is overactivated in corticolimbic parvalbumin-positive GABAergic interneurons in Grin1 mutant mice. Here we addressed whether GSK3β inhibition reverses both abnormal gamma oscillations and behavioral deficits with high correlation by pharmacological and genetic approach. We demonstrated that the paralog selective-GSK3β inhibitor, but not GSK3α inhibitor, normalizes the diminished ASSRs, excessive baseline gamma power, and deficits in spatial working memory and prepulse inhibition (PPI) of acoustic startle in Grin1 mutant mice. Cell-type specific GSK3B knockdown, but not GSK3A knockdown, also reversed abnormal gamma oscillations and behavioral deficits. Moreover, GSK3B knockdown, but not GSK3A knockdown, reverses the mutants’ in vivo spike synchrony deficits. Finally, ex vivo patch-clamp recording from pairs of neighboring cortical pyramidal neurons showed a reduction of synchronous spontaneous inhibitory-postsynaptic-current events in mutants, which was reversed by GSK3β inhibition genetically and pharmacologically. Together, GSK3β inhibition in corticolimbic interneurons ameliorates the deficits in spatial working memory and PPI, presumably by restoration of synchronous GABA release, synchronous spike firing, and evoked-gamma power increase with lowered baseline power. Springer International Publishing 2020-08-28 2020-12 /pmc/articles/PMC7784891/ /pubmed/32859995 http://dx.doi.org/10.1038/s41386-020-00819-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Nakao, Kazuhito Singh, Mahendra Sapkota, Kiran Hagler, Bailey C. Hunter, Robert N. Raman, Chander Hablitz, John J. Nakazawa, Kazu GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia |
title | GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia |
title_full | GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia |
title_fullStr | GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia |
title_full_unstemmed | GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia |
title_short | GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia |
title_sort | gsk3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of nmda receptor hypofunction relevant to schizophrenia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784891/ https://www.ncbi.nlm.nih.gov/pubmed/32859995 http://dx.doi.org/10.1038/s41386-020-00819-0 |
work_keys_str_mv | AT nakaokazuhito gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia AT singhmahendra gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia AT sapkotakiran gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia AT haglerbaileyc gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia AT hunterrobertn gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia AT ramanchander gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia AT hablitzjohnj gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia AT nakazawakazu gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia |